Inhibition of ErbB receptor or knocking-down EREG suppressed ERK signaling, decreased expression of stemness-associated genes and finally affected the stemness of resistant cancer cells, which could re-sensitize the resistant cancer cells to chemo-drugs. The gene discussed is EREG; the disease is cancer.